Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.Journal of Neuro-Oncology|May 6, 2015
Calcification in high grade gliomas treated with bevacizumabDeborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.Neuro-Oncology|July 10, 2020
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition geneLisa A Cannon-Albright, James M Farnham, Jeffrey Stevens, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 17, 2017
Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literatureEfrat Gelerstein, Assaf Berger, Tali Jonas-Kimchi, et al.Journal of Neurosurgery|November 26, 2014
Conflicting pathology reports: a diagnostic dilemmaTal Shahar, Uri Rozovski, Yuval Shapira, et al.American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.Journal of Neuro-Oncology|January 5, 2008
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)Lode J Swinnen, Cathryn Rankin, Hetty Carraway, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 20, 2012
The impact of enrollment in clinical trials on survival of patients with glioblastomaTal Shahar, Erez Nossek, David M Steinberg, et al.Neuro-Oncology|September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.Journal of Neuro-Oncology|January 15, 2018
Neurologic complications of immune checkpoint inhibitorsAvi Fellner, Chen Makranz, Michal Lotem, et al.Pageof 8